Cytovia.png
Cytovia Therapeutics Expands Leadership Team
May 13, 2021 09:48 ET | Cytovia Therapeutics
Jason Aryeh elected to Board of DirectorsElizabeth Schwarzbach, PhD and Boris Reznik, PhD join Strategic Advisory BoardElysa Mantel appointed as Vice President, General Counsel and Corporate Secretary...
lumos.png
Lumos Pharma to Participate in the Oppenheimer Rare & Orphan Disease Summit
May 13, 2021 09:00 ET | Lumos Pharma, Inc.
AUSTIN, Texas, May 13, 2021 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (NASDAQ:LUMO), a clinical-stage biopharmaceutical company focused on therapeutics for rare diseases, announced that the Company...
Certara-CMYK-01.jpg
Certara Releases New Versions of Its Preeminent Quantitative Systems Pharmacology (QSP) Simulators for Expediting Development of Biologics and Immuno-oncology Therapies
May 13, 2021 08:00 ET | Certara
PRINCETON, N.J., May 13, 2021 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), the global leader in biosimulation, today announced the launch of new versions of its Immunogenicity (IG) and...
PDS Biotech Logo.png
PDS Biotech Provides Business Update and Reports First Quarter 2021 Financial Results
May 13, 2021 07:00 ET | PDS Biotechnology Corporation
FLORHAM PARK, N.J., May 13, 2021 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing novel cancer therapies and infectious disease...
Adverum_Primary_Medium.png
Adverum Stockholders Re-Elect All Adverum Director Nominees at 2021 Annual Meeting
May 12, 2021 13:05 ET | Adverum Biotechnologies, Inc.
REDWOOD CITY, Calif., May 12, 2021 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage gene therapy company targeting unmet medical needs in ocular and rare diseases,...
Philogen logo.png
Philogen Announces First Quarter 2021 Results and Provides Update on Pipeline Progress
May 12, 2021 13:00 ET | Philogen
Philogen Announces First Quarter 2021 Results and Provides Update on Pipeline Progress May 12, 2021 NidlegyTM on track for Phase III European trial in stage IIIB/C melanoma. Opening of additional...
Immunicum Announces Presentations at the European Hematology Association (EHA) 2021 Virtual Congress
May 12, 2021 10:02 ET | Immunicum AB
Press Release 12 May 2021 Immunicum Announces Presentations at the European Hematology Association (EHA) 2021 Virtual Congress Immunicum AB (publ; IMMU.ST) today announced that it will be...
Immunicum håller presentationer vid European Hematology Association (EHA) 2021 Virtual Congress
May 12, 2021 10:02 ET | Immunicum AB
Pressrelease 12 maj 2021 Immunicum håller presentationer vid European Hematology Association (EHA) 2021 Virtual Congress Immunicum AB (publ; IMMU.ST) tillkännagav idag att bolaget kommer att...
Neoleukin.png
Neoleukin Therapeutics Announces First Quarter 2021 Financial Results and Corporate Update
May 12, 2021 08:00 ET | Neoleukin Therapeutics, Inc.
- Entered clinical development with first patient dosed in Phase 1 Trial of NL-201 - - Appointed Priti Patel, M.D., as Chief Medical Officer - - Cash and cash equivalents of $178.4 million expected...
Logo.jpg
Celsion Receives $1.85 Million from the Sale of its New Jersey State Net Operating Losses
May 11, 2021 08:00 ET | Celsion CORP
Non-Dilutive Funding Strengthens Balance Sheet, Extends Cash Runway Beyond 2024 Sale of an Additional $5.0 Million of State NOLs Expected in Future Years LAWRENCEVILLE, N.J., May 11, 2021 ...